AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.¹

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to seniors' distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

¹WHO, Oct 2022

Key Information As of 06/28/24

Inception Date	05/09/16
Total Expense Ratio	0.50%
Net Assets	$58.61 million
NAV	$30.06
Fact Sheet	View the document

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 06/27/24

Ticker	AGNG
Bloomberg Index Ticker	ILNGRNT
CUSIP	37954Y772
ISIN	US37954Y7720
Primary Exchange	Nasdaq
Shares Outstanding	1,950,000
Number of Holdings	85
30-Day Median Bid-Ask Spread	0.33%

Distributions As of 06/28/24

30-Day SEC Yield	0.97%
Distribution Frequency	Semi-Annually

ETF Prices As of 06/28/24

NAV	$30.06	Daily Change	-$0.04	-0.13%
Market Price	$30.08	Daily Change	-$0.08	-0.27%

As of recent (03/31/24) As of recent (03/31/24)	Fund NAV	Market Price	Index
1 Year	12.59%	13.50%	12.98%
3 Years	3.44%	3.51%	3.67%
5 Years	7.66%	7.65%	7.90%
Since Inception	9.77%	10.13%	10.05%
1 Year	10.08%	10.62%	10.45%
3 Years	1.25%	1.33%	1.39%
5 Years	8.80%	8.68%	9.05%
Since Inception	9.41%	9.72%	9.69%
Year-to-Date	5.09%	5.87%	5.14%
1 Month	2.64%	2.10%	2.74%
3 Months	5.09%	5.87%	5.14%
Since Inception	108.76%	114.23%	113.11%
Year-to-Date	3.96%	4.47%	4.06%
1 Month	3.24%	3.48%	3.30%
3 Months	1.54%	0.75%	1.68%
Since Inception	106.53%	111.39%	110.91%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
3.47	LLY	ELI LILLY & CO	2516152	905.38	2,247	2,034,388.86
3.37	NOVOB DC	NOVO NORDISK A/S-B	BP6KMJ1	144.52	13,681	1,977,179.96
3.37	AMGN	AMGEN INC	2023607	312.45	6,322	1,975,308.90
3.36	WELL	WELLTOWER INC	BYVYHH4	104.25	18,888	1,969,074.00
3.33	REGN	REGENERON PHARMACEUTICALS	2730190	1,051.03	1,855	1,949,660.65
3.27	AZN	ASTRAZENECA PLC-SPONS ADR	2989044	77.99	24,577	1,916,760.23
3.26	BSX	BOSTON SCIENTIFIC CORP	2113434	77.01	24,795	1,909,462.95
3.17	ALC SW	ALCON INC	BJT1GR5	89.27	20,789	1,855,879.79
3.03	4519 JP	CHUGAI PHARMA CO	6196408	35.53	50,005	1,776,877.91
2.98	ABBV	ABBVIE INC	B92SR70	171.52	10,188	1,747,445.76
2.94	EW	EDWARDS LIFESCIENCES CORP	2567116	92.37	18,670	1,724,547.90
2.86	SYK	STRYKER CORP	2853688	340.25	4,928	1,676,752.00
2.86	JNJ	JOHNSON & JOHNSON	2475833	146.16	11,470	1,676,455.20
2.86	RO SW	ROCHE HOLDING AG-BR	7108918	304.70	5,495	1,674,305.59
2.79	MDT	MEDTRONIC PLC	BTN1Y11	78.71	20,768	1,634,649.28
2.55	UCB BB	UCB SA	5596991	148.65	10,047	1,493,509.35
2.46	BMY	BRISTOL-MYERS SQUIBB CO	2126335	41.53	34,735	1,442,544.55
2.42	068270 KS	CELLTRION INC	B0C5YV1	126.63	11,194	1,417,445.84
2.36	DXCM	DEXCOM INC	B0796X4	113.38	12,219	1,385,390.22
2.17	4543 JP	TERUMO CORP	6885074	16.49	76,985	1,269,682.99
1.96	ZBH	ZIMMER BIOMET HO	2783815	108.53	10,565	1,146,619.45
1.80	VTR	VENTAS INC	2927925	50.81	20,728	1,053,189.68
1.73	STMN SW	STRAUMANN HOLDING AG-REG	BQ7ZV06	123.86	8,204	1,016,142.00
1.62	SOON SW	SONOVA HOLDING AG-REG	7156036	308.92	3,067	947,472.96
1.58	4503 JP	ASTELLAS PHARMA INC	6985383	9.88	93,667	925,839.43
1.46	GMAB DC	GENMAB A/S	4595739	250.78	3,411	855,421.66
1.38	SDZ SW	SANDOZ GROUP AG	BLPLD38	36.21	22,263	806,185.20
1.32	UTHR	UNITED THERAPEUTICS CORP	2430412	318.55	2,422	771,528.10
1.28	COH AU	COCHLEAR LTD	6211798	221.83	3,373	748,221.48
1.24	PODD	INSULET CORP	B1XGNW4	201.80	3,603	727,085.40
1.20	NBIX	NEUROCRINE BIOSC	2623911	137.67	5,119	704,732.73
1.20	BGNE	BEIGENE LTD-ADR	BYYWPW6	142.67	4,921	702,079.07
1.20	INCY	INCYTE CORP	2471950	60.62	11,551	700,221.62
1.09	3692 HK	HANSOH PHARMACEU	BJYKB72	2.09	306,243	640,147.27
1.07	DVA	DAVITA INC	2898087	138.57	4,532	627,999.24
0.99	FME GR	FRESENIUS MEDICAL CARE AG	5129074	38.33	15,187	582,055.75
0.96	SN/ LN	SMITH & NEPHEW PLC	0922320	12.40	45,262	561,054.73
0.87	TFX	TELEFLEX INC	2881407	210.33	2,417	508,367.61
0.86	DEMANT DC	DEMANT A/S	BZ01RF1	43.32	11,594	502,203.39
0.74	OHI	OMEGA HEALTHCARE	2043274	34.25	12,670	433,947.50
0.71	AMP IM	AMPLIFON SPA	B14NJ71	35.63	11,720	417,526.18
0.68	EXAS	EXACT SCIENCES CORP	2719951	42.25	9,377	396,178.25
0.62	ENSG	ENSIGN GROUP INC/THE	B1YWPP8	123.69	2,927	362,040.63
0.60	EXEL	EXELIXIS INC	2576941	22.47	15,663	351,947.61
0.59	HALO	HALOZYME THERAPEUTICS INC	2975098	52.36	6,569	343,952.84
0.58	BPMC	BLUEPRINT MEDICINES CORP	BWY52P3	107.78	3,165	341,123.70
0.54	YPSN SW	YPSOMED HOLDING AG-REG	B02SWN8	447.36	701	313,601.16
0.52	GKOS	GLAUKOS CORP	BYMWL19	118.35	2,556	302,502.60
0.44	MMSI	MERIT MEDICAL SYSTEMS INC	2580555	85.95	2,996	257,506.20
0.41	AGIO	AGIOS PHARMACEUTICALS INC	BCBVTX1	43.12	5,588	240,954.56
0.41	SILK	SILK ROAD MEDICAL INC	BGHVXJ7	27.04	8,846	239,195.84
0.37	GN DC	GN STORE NORD A/S	4501093	27.90	7,811	217,888.98
0.36	AGL	AGILON HEALTH INC	BLR4TK4	6.54	32,084	209,829.36
0.35	NVCR	NOVOCURE LTD	BYSS4X4	17.13	12,110	207,444.30
0.35	MNKD	MANNKIND CORP	BF081J4	5.22	39,265	204,963.30
0.35	DNLI	DENALI THERAPEUTICS INC	BD2B4V0	23.22	8,802	204,382.44
0.35	NHC	NATIONAL HEALTHCARE CORP	2139731	108.40	1,880	203,792.00
0.34	ITGR	INTEGER HOLDINGS CORP	BD06LM7	115.79	1,730	200,316.70
0.34	PHM SM	PHARMA MAR SA	BMW2GT8	34.10	5,776	196,980.14
0.33	EMBC	EMBECTA CORP	BMXWYR1	12.50	15,536	194,200.00
0.33	NHI	NATL HEALTH INVESTORS INC	2626125	67.73	2,864	193,978.72
0.32	SBRA	SABRA HEALTH CAR	B5NLBP6	15.40	12,234	188,403.60
0.31	LTC	LTC PROPERTIES INC	2498788	34.50	5,316	183,402.00
0.31	SIA CN	SIENNA SENIOR LIVING INC	BWTYXH4	10.41	17,387	181,068.26
0.30	9229 JP	SUNWELS CO LTD	BNTYNB5	16.37	10,734	175,763.74
0.30	CSH-U CN	CHARTWELL RETIRE	B8S8C94	9.39	18,655	175,186.72
0.30	BKD	BROOKDALE SR	B0PZN33	6.83	25,360	173,208.80
0.29	LIVN	LIVANOVA PLC	BYMT0J1	54.82	3,119	170,983.58
0.29	AMED	AMEDISYS INC	2024332	91.80	1,829	167,902.20
0.28	AED BB	AEDIFICA	B1G5XP1	60.71	2,745	166,662.27
0.28	2186 HK	LUYE PHARMA GROUP LTD	BNQ4GF3	0.35	475,024	164,275.53
0.27	8086 JP	NIPRO CORP	6641599	7.84	20,454	160,404.83
0.27	TBPH	THERAVANCE BIOPHARMA INC	BMNDK09	8.48	18,861	159,941.28
0.27	ACAD	ACADIA PHARMACEU	2713317	16.25	9,825	159,656.25
0.27	145720 KS	DENTIUM CO LTD	BF07GJ6	85.94	1,810	155,556.12
0.25	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	0.68	220,702	148,973.99
0.25	EKTAB SS	ELEKTA AB-B SHS	B0M42T2	6.25	23,060	144,149.50
0.23	RYM NZ	RYMAN HEALTHCARE LTD	6161525	2.17	62,560	135,710.78
0.23	1789 HK	AK MEDICAL HOLDINGS LTD	BFD6SZ0	0.55	245,689	135,630.25
0.23	1302 HK	LIFETECH SCIENTIFIC CORP	BV9FKS0	0.18	750,292	133,579.15
0.22	ATEC	ALPHATEC HOLDINGS INC	BD60BG7	10.45	12,203	127,521.35
0.21	ALEC	ALECTOR INC	BJ4LDC4	4.54	26,956	122,380.24
0.19		CASH		1.00	112,394	112,393.64
0.10	2500 HK	VENUS MEDTECH -H	BL6V047	0.54	102,940	55,574.47
0.07		OTHER PAYABLE & RECEIVABLES		1.00	39,970	39,969.92
0.01		KOREAN WON		0.00	9,883,820	7,180.40
0.01		CANADIAN DOLLAR		0.73	4,297	3,140.16
0.00		AMPLIFON SPA - RTS	BS4BKD7	0.00	12,182	0.28
0.00		CURRENCY CONTRACT - USD		0.00	-26,058	-0.98
0.00		JAPANESE YEN		0.01	-301,614	-1,875.01
0.00		EURO		1.07	-2,383	-2,553.76
		CURRENCY CONTRACT - USD		0.00	3,337
		RADIUS HEALTH INC - CVR	2KFF9T0	0.00	19,104

Holdings are subject to change. "Cash" denotes U.S. dollars.

Exposure As of 05/31/24

	Sector	Weight (%)
	Health Care	92.9
	Real Estate	7.1

Source: new windowAltaVista Research, LLC

	Industry	Weight (%)
	Medical Specialties	38.5
	Pharmaceuticals: Major	24.9
	Biotechnology	17.0
	Real Estate Investment Trusts	7.7
	Pharmaceuticals: Other	6.1
	Medical/Nursing Services	3.6
	Hospital/Nursing Management	1.3
	Telecommunications Equipment	0.4
	Electrical Products	0.4
	Other	0.1

Source: new windowAltaVista Research, LLC

	Country	Weight (%)
	United States	53.1
	Switzerland	11.2
	Japan	7.0
	Denmark	6.2
	Britain	5.1
	China	3.9
	Ireland	2.9
	South Korea	2.7
	Belgium	2.7
	Germany	1.4
	Australia	1.3
	Other	2.5

Source: new windowAltaVista Research, LLC

All Sector, Industry and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.

ETF Characteristics As of 06/27/24

Return on Equity	13.20%
Weighted Avg. Market Cap	114,282 M
	2023	2024
Price-to-earnings	26.23	25.58
Price-to-book value	3.51	3.25

Source: new windowAltaVista Research, LLC

ETF Risk Stats As of 05/31/24

Versus	Beta
S&P 500	0.73
NASDAQ-100	0.51
MSCI EAFE	0.78
MSCI Emg. Mkts	0.53
Standard Deviation	16.10%

Source: new windowAltaVista Research, LLC

ETF Research

ETF Documents

Latest Premium / Discount As of 06/28/24

NAV	$30.06
Market Price	$30.08
Premium / (Discount)	$0.02

Current View 2024 Q2 As of 06/28/24

Days at Premium	59
Days at NAV	0
Days at Discount	4
Greatest Premium	0.75%
Greatest Discount	-0.30%

Daily Premium / Discount History As of 06/28/24

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Demographics Drive Consumption

Unconstrained Approach

Key Information As of 06/28/24

ETF Summary

ETF Objective

Trading Details As of 06/27/24

Distributions As of 06/28/24

ETF Prices As of 06/28/24

Performance History

Top Holdings As of 06/28/24

Exposure As of 05/31/24

ETF Characteristics As of 06/27/24

ETF Risk Stats As of 05/31/24

ETF Research

Investing in Pharma: How to Spot Leading Drug Candidates

Investing in Pharma: The Drug Lifecycle

In the Pipeline: Top Drug Candidates for FDA Approval in 2024

ETF Documents